Role of cerebral vasculature in brain ischemia in HIV infection

Information

  • Research Project
  • 10160501
  • ApplicationId
    10160501
  • Core Project Number
    R01HL126559
  • Full Project Number
    2R01HL126559-05A1
  • Serial Number
    126559
  • FOA Number
    PA-19-056
  • Sub Project Id
  • Project Start Date
    9/15/2014 - 10 years ago
  • Project End Date
    7/31/2025 - 7 months from now
  • Program Officer Name
    WARREN, RONALD Q
  • Budget Start Date
    9/15/2021 - 3 years ago
  • Budget End Date
    7/31/2022 - 2 years ago
  • Fiscal Year
    2021
  • Support Year
    05
  • Suffix
    A1
  • Award Notice Date
    9/15/2021 - 3 years ago

Role of cerebral vasculature in brain ischemia in HIV infection

ABSTRACT Cerebral small vessel disease (CSVD) and transient ischemic attacks (TIAs) are emerging comorbidities of neuroHIV. The application is built on the most important findings from the previous funding cycle and will evaluate the mechanistic events underlying the impact of HIV on CSVD in relationship to TIA outcome and recovery (Aim 1) and HIV reactivation in the CNS and its egress into the periphery (Aim 2). The significance of the proposed work drives primarily from the facts that CSVD is the major cause of cognitive impairment, contributes to 25% of incidents of brain ischemia, and more than doubles the risk of their recurrence. In addition, the risk of developing transient ischemic attacks (TIAs) or other forms of brain ischemia is estimated to be at least 1.5-2-fold higher in HIV-positive individuals compared to the control population. The central hypothesis of the present proposal is that HIV-induced cerebral vascular pathology drives neuroimmune activation, predisposing HIV-infected brains to the development of CSVD and more severe TIA outcomes. Mechanistically, we will focus on the impact of HIV and CSVD on reprogramming of mitochondria and the role of dysfunctional mitochondria in these events. Our important preliminary data indicates that HIV can be reactivated from latently infected HIV brains, and we show for the first time that this process also occurs as the result of brain ischemia. We will further explore these processes, and will evaluate if reactivated HIV in the CNS can egress into the periphery. The proposed research is highly innovative by its focus on novel mechanisms underlying vascular comorbidities, such as CSVD and TIAs, in the HIV-infected brain. When completed, our application will provide critical insight into the role of HIV in CSVD and TIA development. In addition, our research will provide important information about the reactivation HIV from the brain and seeding into the periphery as the result of brain ischemia. The proposed studies are innovative and are likely to identify novel opportunities for therapeutic intervention.

IC Name
NATIONAL HEART, LUNG, AND BLOOD INSTITUTE
  • Activity
    R01
  • Administering IC
    HL
  • Application Type
    2
  • Direct Cost Amount
    359350
  • Indirect Cost Amount
    192252
  • Total Cost
    551602
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    839
  • Ed Inst. Type
    SCHOOLS OF MEDICINE
  • Funding ICs
    NHLBI:551602\
  • Funding Mechanism
    Non-SBIR/STTR RPGs
  • Study Section
    HVCD
  • Study Section Name
    HIV Molecular Virology, Cell Biology, and Drug Development Study Section
  • Organization Name
    UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
  • Organization Department
    BIOCHEMISTRY
  • Organization DUNS
    052780918
  • Organization City
    CORAL GABLES
  • Organization State
    FL
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    331462926
  • Organization District
    UNITED STATES